Drugs for Charcot-Marie-Tooth Disease, Demyelinating, Type 1a (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 25)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Baclofen |
Approved |
Phase 3 |
|
1134-47-0 |
2284 |
Synonyms:
(+-)-Baclofen
4-Amino-3-(4-chlorophenyl)butyrate
4-Amino-3-(4-chlorophenyl)butyric acid
Alphapharm brand OF baclofen
apo Baclofen
apo-Baclofen
ApoBaclofen
Apotex brand OF baclofen
Ashbourne brand OF baclofen
ASTA medica brand OF baclofen
Athena brand OF baclofen
Atrofen
AWD, baclofen
b-(4-Chlorophenyl)gaba
b-(Aminomethyl)-4-chlorobenzenepropanoate
b-(Aminomethyl)-4-chlorobenzenepropanoic acid
b-(Aminomethyl)-p-chlorohydrocinnamate
b-(Aminomethyl)-p-chlorohydrocinnamic acid
b-(p-Chlorophenyl)-g-aminobutyrate
b-(p-Chlorophenyl)-g-aminobutyric acid
BA-34647
BACLOFEN
Baclofen alphapharm brand
Baclofen apotex brand
Baclofen ashbourne brand
Baclofen athena brand
Baclofen awd
Baclofen ciba-geigy brand
Baclofen irex brand
Baclofen isis brand
Baclofen medtronic brand
Baclofen novartis brand
Baclofen nu-pharm brand
Baclofen pharmascience brand
Baclofene
Baclofène
Baclofène irex
Baclofène-irex
BaclofèneIrex
Baclofeno
Baclofenum
Baclon®|Kemstro®|Lioresal®
Baclophen
Baclospas
BACLOSPAS-10
beta-(4-Chlorophenyl)gaba
beta-(Aminomethyl)-4-chlorobenzenepropanoate
beta-(Aminomethyl)-4-chlorobenzenepropanoic acid
beta-(Aminomethyl)-p-chlorohydrocinnamate
beta-(Aminomethyl)-p-chlorohydrocinnamic acid
|
beta-(p-Chlorophenyl)-gamma-aminobutyrate
beta-(p-Chlorophenyl)-gamma-aminobutyric acid
Chlorophenyl gaba
Ciba geigy brand OF baclofen
CIBA34,647ba
CIBA-34,647-ba
Ciba-geigy brand OF baclofen
Clofen
DL-4-Amino-3-p-chlorophenylbutanoate
DL-4-Amino-3-p-chlorophenylbutanoic acid
DL-Baclofen
GABA, chlorophenyl
GABLOFEN
g-Amino-b-(p-chlorophenyl)butyrate
g-Amino-b-(p-chlorophenyl)butyric acid
gamma-Amino-beta-(p-chlorophenyl)butyrate
gamma-Amino-beta-(p-chlorophenyl)butyric acid
Gen baclofen
Gen-baclofen
GenBaclofen
Genpharm
Irex brand OF baclofen
Isis brand OF baclofen
Kemstro
Lebic
Lioresal
LIORESAL INTRATH
LYFLEX
Medtronic brand OF baclofen
Novartis brand OF baclofen
Nu baclo
Nu pharm brand OF baclofen
Nu-baclo
NuBaclo
Nu-pharm brand OF baclofen
PCP-GABA
Pharmascience brand OF baclofen
PMS Baclofen
PMSBaclofen
PMS-Baclofen
Î’-(4-chlorophenyl)gaba
Î’-(aminomethyl)-4-chlorobenzenepropanoate
Î’-(aminomethyl)-4-chlorobenzenepropanoic acid
Î’-(aminomethyl)-p-chlorohydrocinnamate
Î’-(aminomethyl)-p-chlorohydrocinnamic acid
Β-(p-chlorophenyl)-γ-aminobutyrate
Β-(p-chlorophenyl)-γ-aminobutyric acid
Γ-amino-β-(p-chlorophenyl)butyrate
Γ-amino-β-(p-chlorophenyl)butyric acid
|
|
2 |
|
Sorbitol |
Approved, Investigational |
Phase 3 |
|
69-65-8, 50-70-4 |
453 6251 5780 |
Synonyms:
(-)-Sorbitol
(−)-SORBITOL
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
7B5697N
ALEXITOL SODIUM
ARIDOL KIT
Baxter brand OF sorbitol
Bronchitol
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-(-)-Sorbitol
D-(−)-SORBITOL
D-Glucitol
Diakarmon
Diosmol
D-Mannitol
D-Sorbit
D-SORBITOL
D-Sorbol
Dulcite
e 420
e 421
e420
e-420
e421
e-421
Esasorb
FEMA NO. 3029
Foodol D 70
FRAXININE
GLC-Ol
Glucarine
Glucitol
g-Ol
Hexahydroxyhexane
Hexanhexol
INS NO.421
INS-421
Invenex
ISOMALT IMPURITY, MANNITOL-
ISOMALT IMPURITY, SORBITOL-
Isotol
Karion
Karion instant
Klysma sorbit
Kyowa powder 50m
L-Gulitol
Manicol
MANITOL
Maniton S
Maniton-S
Manna sugar
Mannazucker
Mannidex
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
MANNITOLUM
|
Mannogem 2080
Marine crystal
Medefield brand OF sorbitol
Medevac
Multitol
Mushroom sugar
Neosorb
Neosorb 20/60dC
Neosorb 70/02
Neosorb 70/70
Neosorb p 20/60
Neosorb p 60
Neosorb p 60W
Nivitin
NSC-25944
NSC-407017
Osmitrol
Osmofundin
Osmosal
Pfizer brand OF sorbitol
Resectisol
Resulax
SDM No. 35
Sionit
Sionit K
Sionite
Sionon
Siosan
Sorbex m
Sorbex R
Sorbex RP
Sorbex S
Sorbex X
Sorbilande
Sorbilax
Sorbit
Sorbit D 70
Sorbit DP
Sorbit DP 50
Sorbit D-powder
Sorbit kyowa powder 50m
Sorbit L 70
Sorbit S
Sorbit T 70
Sorbit W 70
Sorbit WP
Sorbit W-powder
Sorbit W-powder 50
Sorbite
SORBITOL
Sorbitol 3% in plastic container
Sorbitol F
Sorbitol FK
Sorbitol FP
Sorbitol pfizer brand
Sorbitol S
Sorbitol syrup C
Sorbitur
Sorbo
Sorbogem 712
Sorbol
Sorbostyl
Tobrex
Trommsdorff brand OF sorbitol
Yal
|
|
3 |
|
Naltrexone |
Approved, Investigational, Vet_approved |
Phase 3 |
|
16590-41-3 |
5360515 |
Synonyms:
(-)NALTREXONE
(-)naltrexone|naltrexone HCl|ReVia®
17-(Cyclopropylmethyl)-4,5a-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one
Antaxone
Bristol myers squibb brand OF naltrexone hydrochloride
Bristol-myers squibb brand OF naltrexone hydrochloride
Celupan
Du pont brand OF naltrexone hydrochloride
EN-1639A
EN-1639A [AS HYDROCHLORIDE]
EN-1639A FREE BASE
Hydrochloride, naltrexone
Lacer brand OF naltrexone hydrochloride
Lamepro brand OF naltrexone hydrochloride
MorViva
Nalorex
Naltrexon
Naltrexona
|
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone [Usan:Ban:Inn]
NALTREXONE HCL
Naltrexone hydrochloride
Naltrexonum
Naltrexonum [INN-Latin]
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Nemexin
Orphan brand OF naltrexone hydrochloride
Pharmazam brand OF naltrexone hydrochloride
PTI-555
ReVia
Schering plough brand OF naltrexone hydrochloride
Schering-plough brand OF naltrexone hydrochloride
TREXAL
Trexan
United drug brand OF naltrexone hydrochloride
Vivitrex
Vivitrol
|
|
4 |
|
Ethanol |
Approved |
Phase 3 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
5 |
|
Ascorbic acid |
Approved, Nutraceutical |
Phase 2, Phase 3 |
|
50-81-7 |
54676860 54670067 5785 |
Synonyms:
(+)-Ascorbate
(+)-Ascorbic acid
(+)-Sodium L-ascorbate
[<sup>14</sup>C]-ascorbic acid
3-keto-L-Gulofuranolactone
3-oxo-L-Gulofuranolactone
AA
Acid, ascorbic
Acid, L-ascorbic
Acide ascorbique
Acido ascorbico
ácido ascórbico
Acidum ascorbicum
Acidum ascorbinicum
Adenex
Allercorb
Antiscorbic vitamin
Antiscorbutic vitamin
arco-Cee
Ascoltin
ASCOR
Ascorb
Ascor-b.i.d.
Ascorbajen
Ascorbate
Ascorbate radical
Ascorbate, ferrous
Ascorbate, magnesium
Ascorbate, sodium
ASCORBIC ACID
Ascorbic acid radical
Ascorbic acid, monosodium salt
Ascorbicab
Ascorbicap
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorin
Ascorteal
Ascorvit
Cantan
Cantaxin
Catavin C
Ce lent
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Ce-mi-lin
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-caps TC
Cetane-caps TD
Cetebe
Cetemican
Cevalin
Cevatine
Cevex
Cevi-bid
Cevimin
Ce-vi-sol
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
|
Ciamin
Cipca
Citriscorb
Citrovit
C-Level
C-Long
Colascor
Concemin
C-Quin
C-Span
C-Vimin
Davitamon C
Di-L-ascorbate, magnesium
Dora-C-500
Duoscorb
e 300
e300
e-300
Ferrous ascorbate
gamma-Lactone L-threo-hex-2-enonate
gamma-Lactone L-threo-hex-2-enonic acid
HiCee
Hybrin
ido-C
Juvamine
Kangbingfeng
Kyselina askorbova
L Ascorbic acid
L(+)-Ascorbate
L-(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbic acid
L-3-Ketothreohexuronic acid lactone
Laroscorbine
L-Ascorbate
L-Ascorbic acid
Lemascorb
Liqui-cee
L-Lyxoascorbate
L-Lyxoascorbic acid
L-threo-Ascorbic acid
L-Xyloascorbate
L-Xyloascorbic acid
Magnesium ascorbate
Magnesium ascorbicum
Magnesium di L ascorbate
Magnesium di-L-ascorbate
Magnorbin
Meri-c
Monodehydroascorbate radical
Monodehydroascorbic acid radical
Natrascorb
Natrascorb injectable
Planavit C
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Semidehydroascorbic acid
Sodascorbate
Sodium ascorbate
Suncoat VC 40
Testascorbic
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100m
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamina C
Vitamisin
Vitascorbol
Xitix
|
|
6 |
|
Vitamins |
|
Phase 2, Phase 3 |
|
|
|
7 |
|
Trace Elements |
|
Phase 2, Phase 3 |
|
|
|
8 |
|
Micronutrients |
|
Phase 2, Phase 3 |
|
|
|
9 |
|
Antioxidants |
|
Phase 2, Phase 3 |
|
|
|
10 |
|
Protective Agents |
|
Phase 2, Phase 3 |
|
|
|
11 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
12 |
|
Cathartics |
|
Phase 3 |
|
|
|
13 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
14 |
|
Laxatives |
|
Phase 3 |
|
|
|
15 |
|
GABA Agonists |
|
Phase 3 |
|
|
|
16 |
|
Gastrointestinal Agents |
|
Phase 3 |
|
|
|
17 |
|
Narcotic Antagonists |
|
Phase 3 |
|
|
|
18 |
|
Narcotics |
|
Phase 3 |
|
|
|
19 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 2 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
20 |
|
Biotin |
Approved, Investigational, Nutraceutical |
Phase 2 |
|
58-85-5 |
253 171548 |
Synonyms:
(+)-Biotin
-(+)-Biotin
(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valerate
(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid
(+)-CIS-HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOLE-4-PENTANOIC ACID
(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valerate
(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid
1SWK
1SWN
1SWR
5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoate
5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid
5-[(1R,5S,6S)-3-OXO-7-THIA-2,4-DIAZABICYCLO[3.3.0]OCT-6-YL]PENTANOIC ACID
5-[(3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOLIDIN-4-YL]PENTANOIC ACID
Biocur brand OF biotin
Biodermatin
Bioepiderm
Biokur
Bios H
Bios II
Biotin
BIOTIN 100
Biotin biocur brand
Biotin dermapharm brand
Biotin gelfert
Biotin hermes
Biotin hermes brand
Biotin medopharm brand
Biotin ratiopharm
Biotin ratiopharm brand
Biotin roche brand
Biotin simons brand
Biotin strathmann brand
Biotin ziethen brand
Biotina
Biotine
Biotine roche
Biotinratiopharm
Biotin-ratiopharm
Biotinum
cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valerate
cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid
cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valerate
cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid
cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valerate
|
cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid
Coenzyme R
D(+)-Biotin
D-(+)-Biotin
D-Biotin
D-Biotin factor S
Deacura
delta-(+)-Biotin
delta-Biotin
delta-Biotin factor S
Dermapharm brand OF biotin
E+b pharma brand OF biotin
Factor S
Factor S (vitamin)
Gabunat
Gelfert, biotin
H, Vitamin
Hermes brand OF biotin
Hermes, biotin
Hexahydro-2-oxo-[3as-(3aa,4b,6aa)]-1H-thieno[3,4-D]imidazole-4-pentanoate
Hexahydro-2-oxo-[3as-(3aa,4b,6aa)]-1H-thieno[3,4-D]imidazole-4-pentanoic acid
Hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-thieno[3,4-D]imidazole-4-pentanoate
Hexahydro-2-oxo-[3as-(3alpha,4beta,6alpha)]-1H-thieno[3,4-D]imidazole-4-pentanoic acid
Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoate
Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoic acid
HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOLE-4-PENTANOIC ACID
Lutavit H2
MD-1003
Medea brand OF biotin sodium salt
Medebiotin
Medobiotin
Medopharm brand OF biotin
Meribin
NSC-63865
Ratiopharm brand OF biotin
Roche brand OF biotin
Roche, biotine
Rombellin
Rovimix H 2
Simons brand OF biotin
Strathmann brand OF biotin
Vitamin b7
Vitamin H
Vitamin-H
Ziethen brand OF biotin
|
|
21 |
|
Folate |
|
Phase 2 |
|
|
|
22 |
|
Vitamin B9 |
|
Phase 2 |
|
|
|
23 |
|
Vitamin B7 |
|
Phase 2 |
|
|
|
24 |
|
Vitamin B Complex |
|
Phase 2 |
|
|
|
25 |
|
Ulipristal acetate |
|
Phase 2 |
|
126784-99-4 |
13559282 130904 |
Synonyms:
(11BETA,17ALPHA)-17-ACETYL-11-[4-(DIMETHYLAMINO)PHENYL]-3-OXOESTRA-4,9-DIEN-17-YL ACETATE
14-Acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-1,6-dien-14-yl acetic acid
17-ACETOXY-11-(4-N,N-DIMETHYLAMINOPHENYL)PREGNA-4,9-DIENE-3,20-DIONE
CDB 2914
CDB-2914
CDB-2914|EllaOne®|VA2914
ELLA
ELLAONE
|
ESMYA
PGL-4001
RTI-3021-012
ULIPRISTAL ACET
ULIPRISTAL ACETATE
Ulipristal acetic acid
VA2914
VA-2914
|
|
Interventional clinical trials:
(show all 23)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Multicenter Study to Evaluate the Effects on Charcot-Marie-Tooth Neuropathy Type 1A of a Composite Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program. |
Unknown status |
NCT01289704 |
Phase 2, Phase 3 |
|
2 |
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months |
Completed |
NCT02579759 |
Phase 3 |
PXT3003 dose 1;PXT3003 dose 2;placebo |
3 |
A Randomized, Placebo-controlled, Double Masked 120 Subject "Futility Design" Clinical Trial of Ascorbic Acid Treatment of Charcot Marie Tooth Disease Type 1A. |
Completed |
NCT00484510 |
Phase 2, Phase 3 |
Ascorbic acid (Vitamin C);placebo |
4 |
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A) Treated 15 Months |
Recruiting |
NCT05092841 |
Phase 3 |
PXT3003;PXT3003 placebo |
5 |
International, Multi-center, Open Label, Follow-up Extension Study Assessing the Long-term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A |
Active, not recruiting |
NCT03023540 |
Phase 3 |
PXT3003 |
6 |
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A) |
Active, not recruiting |
NCT04762758 |
Phase 3 |
(RS)-baclofen, naltrexone hydrochloride and D-sorbitol;Placebo |
7 |
SERENDEM Study: MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study |
Completed |
NCT02967679 |
Phase 2 |
MD1003 |
8 |
A Phase II, Randomized, Placebo-controlled Trial of the Safety, Efficacy, Pharmacodynamics and Pharmacokinetics of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A. |
Completed |
NCT01401257 |
Phase 2 |
PXT3003 Low dose;PXT3003 Intermediate Dose;PXT3003 High Dose |
9 |
Single Center, Open Label, Repeat Intramuscular Administration, 270 Days, Phase I/2a Clinical Trial to Evaluate Safety, Tolerability of Investigational Product (Engensis: VM202) With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A) |
Completed |
NCT05361031 |
Phase 1, Phase 2 |
|
10 |
Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) |
Suspended |
NCT03520751 |
Phase 1, Phase 2 |
scAAV1.tMCK.NTF3 |
11 |
LONG-TERM EFFECTS TOLERANCE AND THE Ulipristal Acetate IN DISEASE Charcot-MARIE-TOOTH TYPE OF 1A |
Terminated |
NCT02600286 |
Phase 2 |
EllaOne;EllaOne placebo |
12 |
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A |
Recruiting |
NCT05333406 |
Phase 1 |
EN001 |
13 |
Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study |
Unknown status |
NCT03550300 |
|
|
14 |
Quantification of Nerve Stiffness in Patients With Peripheral Neuropathies |
Unknown status |
NCT03397303 |
|
|
15 |
The Feasibility and Effect of Ankle Foot Orthoses and Underfoot Vibration on the Postural Stability of People With Inherited Neuropathy |
Unknown status |
NCT03278093 |
|
|
16 |
Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A |
Completed |
NCT01750710 |
|
|
17 |
BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease |
Completed |
NCT02982343 |
|
|
18 |
Biomarkers and Validation of Selected Outcome Measures (CMTNSmod) |
Completed |
NCT03386266 |
|
|
19 |
A Randomized Double Blind Longitudinal Study to Determine Motor Unit Number Index Variability in CMT1A Patients Undergoing a Home Ankle Strengthening Program Versus Standard of Care |
Completed |
NCT03715283 |
|
|
20 |
Driving Ability in Patients With CMT 1A |
Completed |
NCT02357355 |
|
|
21 |
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers |
Recruiting |
NCT02596191 |
|
|
22 |
Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test |
Recruiting |
NCT05142059 |
|
|
23 |
Genetics of Charcot Marie Tooth Disease (CMT) - Modifiers of CMT1A, New Causes of CMT |
Recruiting |
NCT01193088 |
|
|
|